Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,948
A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Dallas TX, Southaven MS, Cincinnati OH, Phoenix AZ
Sponsor: Astellas Institute for Regenerative Medicine
Sex: All
Age: 6+
Code: NCT07734064
Phase 1, Recruiting
Study of ON 123300 in Patients With Advanced Cancer
for
Solid Tumors, Adult
Location: Dallas TX, Greenville SC, Grand Rapids MI
Sponsor: Traws Pharma, Inc.
Sex: All
Age: 18+
Code: NCT04739293
Phase 1, Recruiting
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Plano TX, Austin TX, Oklahoma City OK, Atlanta GA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 0+
Code: NCT06480383
Phase 2, Recruiting
Binocular Amblyopia Treatment
for
Amblyopia
Location: Dallas TX
Sponsor: Retina Foundation of the Southwest
Sex: All
Age: 4 - 10
Code: NCT03288948
Recruiting
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients
for
LCA5
Location: Dallas TX, Philadelphia PA
Sponsor: Opus Genetics, Inc
Sex: All
Age: 4+
Code: NCT05616793
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
Location: Dallas TX, Aurora CO, Miami FL, Boston MA, Portland OR
Sponsor: Splice Bio
Sex: All
Age: 12 - 65
Code: NCT06942572
Phase 1, Phase 2, Recruiting
Patch-free Occlusion Therapy
for
Amblyopia
Location: Dallas TX
Sponsor: Retina Foundation of the Southwest
Sex: All
Age: 3 - 12
Code: NCT05440448
Recruiting
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
for
Breast Cancer
Location: Fort Worth TX, Spring TX, Germantown TN, Kansas City MO,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06790693
Phase 3, Recruiting
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene